Mulsant BH
Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
ArticlePsilocybin
Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review.
ArticlePsilocybin
Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.
ArticlePsilocybin
Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials.
ArticlePsilocybin
Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.
ArticlePsilocybin
Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial.
ArticlePsilocybin
Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?
ArticlePsilocybin
A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.
ArticlePsilocybin